Apmefx | Logo
menu-icon
Products
Who we are
Legal
Metatrader
Global Business: Winners and Losers of the Pandemic Crisis Are on the Increase

Although this year’s economic growth has been fast so far as expected, another wave of the pandemic, especially as a result of the Delta variant, may have negative effects. There are some signals of such development: the US service sector saw a slowdown in June and the growth in Chinese plants was at a four-month low. Oil prices have also experienced a decline as a response to the rapid spread of Delta.

 

Predominantly the travel industry is among the sectors that may suffer new hits after a short recovery. This is explicitly confirmed, for example, by the UN stating that this year, the global economy may see a production decline of nearly USD 2.4 trillion as reported in 2020, primarily as a consequence of the pandemic impact on travelling and its related industries.

 

On the other hand, industries that primarily profit from the repeated fall in the epidemic data, and the resulting reassessment of originally optimistic expectations relating to the speed of economic recovery, may continue to include pharmacy, biotechnologies, and medical supplies and services.

 

According to a study of APME FX, the companies that deserve a long-term attention in the above-mentioned sectors comprise namely BioNTech (pharmacy), Regeneron (biotechnologies), Medtronic (medical technologies and equipment) and UnitedHealth Group (insurance). The companies came with effective vaccines (BioNTech) or drugs (Regeneron) against SARS-CoV-2 in record time, which was reflected in their sales significantly. This was also driving the market value of those companies, which was the case of the medical giant Medtronic and Moderna that made a great achievement in mid-July when it was added to the S&P 500. The company’s stocks grew several times over the last year.

 

Out of the largest health insurance companies, significantly positive data since the start of the pandemic has been reported by UnitedHealth Group. For more details on the performance of the companies selected by APME FX, refer to the World Health Care Investments 2021 study here.

Peter Svoreň, APME FX

Disclaimer:

The material herein is considered as marketing communication under the relevant laws and regulations, and as such is not a subject to any prohibition on dealing ahead of the dissemination of investment research. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and should not be construed as containing investment advice, or an investment recommendation, or an offer of or solicitation for any transactions in financial instruments. The published content is intended for educational/informational purposes only. It does not take into account readers’ financial situation, personal experience or investment objectives. APME FX Trading Europe Ltd makes no representation that the information provided is accurate, current or complete; and therefore, assumes no liability for any losses arising from investments based on the supplied content. The past performance is not a guarantee of future results.

Apme Fx | German economic engine in trouble. The cause is automotive, which is lagging behind

Blog

German economic engine in trouble. The cause is automotive, which is lagging behind

Germany has the largest economy in Europe and one of the highest living standards in the world. Yet in recent years we hear that Germany is the sick man of Europe and that its economy is losing its brea...

Apme Fx | Eurozone economic growth stay below one percent this year. It will accelerate in 2025 thank to household consumption

Blog

Eurozone economic growth stay below one percent this year. It will accelerate in 2025 thank to household consumption

The Eurozone economy is only slowly looking for a way to faster growth. The gross domestic product of euro-area countries should increase by just under one percent this year. At the same time, economic...

Apme Fx | Inflation in Euro area slightly above the target. What to expect from ECB in the rest of 2024?

Blog

Inflation in Euro area slightly above the target. What to expect from ECB in the rest of 2024?

Annual inflation rate in Euro area rose in July to 2.6 percent according to Eurostat which represented a slight increase in comparison to June (2.5 percent). The closest monetary policy meeting of ECB w...

CFDs are complex instruments and carry a high risk of losing money quickly due to leverage, 82.99% of retail investors' accounts are lost when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing money. Please read the Risk Warning.